5Chiu J S,Wang Y F,Su Y C,et al.Artificial neural network topredict skeletal metastasis in patients with prostate cancer[J].J Med Syst,2009,33(2):91-100.
7Bostwick D G,Pacelli A,Biute M,et al.Prostate specific mem-brane antigen expression in prostatic intraepithelial neoplasiaand adenocarcinoma:study of 184cases[J].Cancer,1998,82(11):2256-2261.
8Marchal C,Redondo M,Padilla M,et al.Expression of prostatespecific membrane antigen(PSMA)in prostatic adenocarcino-ma and prostatic intraepithelial neoplasia[J].Histopathol,2004,19(3):715-718.
9Ross S,Spencer S D,Holcomb I,et al.Prostate stem cell anti-gen as therapy target tissue expression and in vivo efficacy ofan immunocon jugate[J].Cancer Res,2002,62(9):2546-2553.
10Alt K,Wiehr S,Ehrlichmann W,et al.High-resolution animalPET imaging of prostate cancer xenografts with three differ-ent 64Cu-labeled antibodies against native cell-adherent PS-MA[J].Prostate,2010,70(13):1413-1421.
9Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin, 2008, 58(2) : 71-96.
10Perner S, Hofer MD, Kim R, et al. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol, 2007, 38(5): 696-701.
6Jemal A, Siegel R, XuJ, et al. Cancer statistics, 2010 I-J-]. Cancer J Clin, 2010, 60(5): 277-300.
7Bubendorf L, Sch6pfer A, Wagner U, et al. Metastat- ic patterns of prostate cancer: an autopsy study of 1, 589 patients[J]. Hum Pathol, 2000, 31(5): 578- 583.
8Coleman R E. Clinical features of metastatic bone dis- ease and risk of skeletal morbidity [J]. Clin Cancer Res, 2006, 12((20 Pt 2): 6243-6249.
9Bokhorst L P, Zhu X, Bul M, et al. Positive predictive value of prostate biopsy indicated by prostate-specific- antigen-based prostate cancer screening: trends over time in a European randomized trial [J]. BJU Int, 2012, 110(10): 1654-1660.
10Naya Y, Okihara K, Evans R B, et al. Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy[J]. Urology, 2005, 66(2): 350 -355.
